Join our upcoming webinar to learn about the MSDA Test in a clinical setting on Dec. 13, 12:00 PM EST Register Today

Our Science

Powerful innovation to transform MS

We're committed to rigorous and ongoing evaluation.

Browse our latest publications below.

Category

1 … 8 9

Proteomic Serum Biomarker Signatures Associated with Patient Reported Outcomes in Multiple Sclerosis

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Integrated Analysis of Novel MRI and Blood Serum Biomarkers for the Estimation and Prediction of MS Disease Activity and Progression

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Development of a Custom Multivariate Proteomic Serum Based Assay for Association with Radiographic and Clinical Endpoints in MS

Research Presented at the Joint ACTRIMS-ECTRIMS Meeting MS Virtual 2020 — September 11-13, 2020

Changes in the Detection of Clinically Relevant White Matter Lesions in MS Using FDA-Cleared Automated Software

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Analytical Validation of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis

Research Presented at the Annual ACTRIMS Meeting Virtual Conference — February 25-27, 2021

Clinical Validation Study Results of a Multivariate Proteomic Serum Based Assay for Disease Activity Assessments in Multiple Sclerosis

Research Presented at the Annual ECTRIMS Meeting Virtual Conference — October 13-15, 2021